Novartis enters into US$390 million settlement

Swiss drug maker Novartis has agreed to pay US state and federal authorities US$390 million to resolve allegations that the company paid kickbacks to speciality pharmacies. In return for kickbacks the pharmacies would recommend Novartis drugs to patients.

Unlock unlimited access to all Global Investigations Review content